Saturday, 16 February 2013

Improved understanding of cancer cell surface protein

Researchers from the University of California and the Lawrence Berkeley National Laboratory have provided important new details about the activation of the epidermal growth factor receptor (EGFR). The receptor is a cell surface protein that has been strongly linked to a large number of cancers and is a major target for cancer therapies.

Jay Groves, one of the leaders of the research, says: "The more we understand about EGFR and the complex molecular machinery involved in the growth and proliferation of cells, the closer we will be to developing new and more effective ways to cure and treat the many different forms of cancer." Groves, who holds positions at both Berkeley Lab's Physical Biosciences Division and UC Berkeley's Chemistry Department, as well as the Howard Hughes Medical Institute, is one of two corresponding authors of a paper in the Journal Cell that describes the research. The other author is John Kuriyan, who also holds positions at Berkeley Lab, UC Berkeley and HHMI.

Once a protein that is coded for by genes has been assembled from amino acids, it may also need to be activated by post-translational processes, such as autophosphorylation in which phosphate is added. Protein activation can affect many important cellular processes including proliferation, differentiation and migration. Cancer is basically a case of these cellular functions gone wild, which often results from problems with the EGFR. However, despite its well-known links to cancer, EGFR activation is only partially understood.

As one of a group of receptors known as receptor tyrosine kinases, EGFR features a ligand-binding domain on its extracellular side and a kinase domain on its intracellular side. The explanation for EGFR activation is that the binding of the ligand, EGF, to its extracellular side induces dimerization of the receptor, the process in which two identical molecules combine to form a single compound molecule. This in turn brings together the kinase domains on the intracellular sides of the dimer, allowing them to phosphorylate one another. Groves believes that while this picture is accurate, it is an oversimplification of the mechanics behind the process because isolated intracellular kinase domains in solution can be active on their own at relatively low concentration, without EGF ligand-induced dimerization.

By measuring autophosphorylation as a function of EGFR, Groves, Kuriyan and their colleagues discovered that structural coupling between the EGFR transmembrane helix and extracellular juxtamembrane modules in addition to EGF ligand-engagement is required for EGFR activation. This structural coupling allows dimerization to take place in the presence of the EGF ligand.

With the mechanics behind EGFR activation now fully explained, Groves and his colleagues are now applying their techniques to another group of receptor tyrosine kinases, the Eph receptors, as well as T cell receptors that are so important to the immune system.

Jack

Saturday, 9 February 2013

MS brain damage could be repaired by skin

Multiple sclerosis, the disease in which the patient's nerve coverings are attacked by their own immune system, is currently incurable, but a group of scientists now believe they have found a way to repair the damage. Researchers say that it may be possible to use a patient's own skin to repair the harm done to their brain by MS.

The body's nerve cells are coated in a substance called myelin which acts as an insulator, but diseases such as MS result in damage to the myelin. This leaves the nerves exposed and as a result electrical signals struggle to travel around the body.

A team of scientists at the University of Rochester Medical Center, in the US, used recent advances in stem-cell science to attempt to repair the myelin. They took a sample of human skin cells and converted them into stem cells, which they then transformed into immature versions of cells in the brain that produce myelin. The cells were inserted into mice born without any myelin and reportedly had a significant effect.

Dr Steven Goldman said: "myelin was produced throughout the nervous system" and some of the mice had been able to achieve "normal life spans". The underlying nerve fibres, which still exist in people with MS, had been successfully re-myelinated, but patients would still have the problem of their immune system attacking the myelin. Therefore any treatment would need to be repeatedly performed or used alongside other therapies that would tame the immune system.

Dr Goldman said that further tests would need to be carried out and the technique still needs to be refined before it can be used in people, but he sees "no reason to be pessimistic" and expects to begin trials within a couple of years.

Dr Emma Gray, from the MS society, commented: "myelin repair therapies are urgently needed in MS and we're pleased to see researchers have been able to generate myelin making cells from human stem cells". She continued to say: "This is still very early stage research, but with more development could one day be used to repair damage to myelin in people with MS. We look forward to seeing more research in this promising area".

Jack

Saturday, 2 February 2013

HIV levels remain level

A failure to curb HIV in gay and bisexual men in England and Wales could be due to a resurgence of risky sexual practice, researchers suggest. The statistics from between 2001 and 2010 show that new infections were static at about 2,300 a year, despite rises in early diagnosis and an increase in people taking medication.

There is concern about the spread of HIV in men who have sex with other men, with the Health Protection Agency's latest report showing HIV had reached an "all-time high" in this group, and more and more new cases are reported each year. As well as this there remains the issue of the long delay between becoming infected and finding out, since some people that are infected are reluctant to be screened.

Between 2001 and 2010 the number of gay or bisexual men being tested in clinics went from 16,000 to 59,000 a year, also the average length of time between infection and diagnosis fell from four years to just over three, and the numbers taking antiretroviral therapy rose from 69% to 80%. Despite these figures the number of new infections remained the same, with the Health Protection Agency saying unsafe sex was "the most plausible explanation" for the findings.

Dr Valerie Delpech, the organisation's head of surveillance, said: "Men who have sex with men should get an HIV and STI screen at least annually, and every three months if having unprotected sex with new or casual partners - and we urge clinicians to take every opportunity to offer the test to this group." Sir Nick Partridge, the chief executive at Terrence Higgins Trust, which campaigns on sexual health, added: "These findings highlight the real challenges faced by HIV prevention work, which need much greater attention." He continued to say that spending on safer sex campaigns had "fallen dramatically" over the last 10 years and "we must challenge the assumptions some gay men make about HIV and re-energise gay communities to tackle a real and growing threat to their sexual health."

Jack